Lamisil® Tablets 250 mg

DRUG2 trials

Sponsors

Mylan Pharmaceuticals Inc

Conditions

Healthy

Phase 1

Fed Study of Terbinafine Hydrochloride Tablets 250 mg and Lamisil® 250 mg

CompletedNCT00648713

Mylan Pharmaceuticals IncHealthy

Start: 2004-02-29End: 2004-03-31Updated: 2024-04-23

Fasting Study of Terbinafine Hydrochloride Tablets 250 mg and Lamisil® Tablets 250 mg

CompletedNCT00647647

Mylan Pharmaceuticals IncHealthy

Start: 2004-02-29End: 2004-03-31Updated: 2024-04-23